FDA Approved: PIPERACILLIN AND TAZOBACTAM — Supplemental Application (Civica, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Civica, Inc. for Piperacillin and Tazobactam (piperacillin/tazobactam).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Infection
• Intra-abdominal Infection
• Pneumonia
• Sepsis
• Skin and Skin Structure Infections
• Urinary Tract Infection

Drugs mentioned

• Piperacillin and tazobactam (Piperacillin and tazobactam)

Snippet

SUPPL AP for PIPERACILLIN AND TAZOBACTAM (PIPERACILLIN AND TAZOBACTAM)